focus -WSS

focus

author：Wikipedia 2025-09-27 12:54:54 - browse：77

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： H.R. 3 is the wrong path to lower drug costs

WSS

What American doctors can learn from their Israeli counterparts

Snackable artificial intelligence, expert AI, and the pharma industry

Flint parents haunted by uncertainty, fears of lead poisoning

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

'Null' research findings aren't empty of meaning. Let's publish them

Listen: Biogen's potential pivot, & Illumina's next chapter

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

House transparency, PBM reform bill gains bipartisan support

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves Sage Therapeutics’ rapid

New air purifier tech could be key to improving indoor air quality

How I helped Pfizer think through the ethics of Viagra

State Dept. review finds Biden bears some blame for Afghanistan failures

How to fix cancer clinical trials' diversity problem

Apple is now the first public company to be valued at $3 trillion

Chris Christie meets with Zelenskyy during Ukraine trip

knowledge

Personalized medicine goes far beyond genetics

How to fix cancer clinical trials' diversity problem

H.R. 3 is the wrong path to lower drug costs

Chris Christie meets with Zelenskyy during Ukraine trip

Biotech startup Celsius cuts 75% of staff ahead of first trial start

When waiting feels immoral: Empathy in the emergency department

Wikipedia

Wikipedia

focus

explore